Clinuvel Pharmaceuticals
CUV.AX
#7392
Rank
HK$3.36 B
Marketcap
HK$67.10
Share price
2.28%
Change (1 day)
9.18%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2024: HK$0.26 Billion

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are HK$58.85 Million. In 2024 the company made an earning of HK$0.26 Billion, an increase over its 2023 earnings that were of HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024HK$0.26 B11.35%
2023HK$0.23 B28.31%
2022HK$0.18 B22.8%
2021HK$0.14 B112.63%
2020HK$70.54 M-28.73%
2019HK$98.98 M32.79%
2018HK$74.54 M75.41%
2017HK$42.49 M-332.52%
2016-HK$18.28 Million-70.68%
2015-HK$62.35 Million53.78%
2014-HK$40.54 Million-16.1%
2013-HK$48.32 Million-37.92%
2012-HK$77.84 Million-18.19%
2011-HK$95.14 Million25.31%
2010-HK$75.93 Million-21.53%
2009-HK$96.76 Million-11.27%
2008-HK$0.11 Billion80.4%
2007-HK$60.46 Million-2.46%
2006-HK$61.98 Million-5.35%
2005-HK$65.48 Million60.55%
2004-HK$40.79 Million97.37%
2003-HK$20.67 Million50.62%
2002-HK$13.72 Million121.22%
2001-HK$6.21 Million254.48%
2000-HK$1.75 Million